Regeneron Pharmaceuticals Inc (REGN) Q4 2022 Earnings Call Transcript

[ad_1] Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ryan Crowe — Vice President, Investor Relations Leonard S. Schleifer — Co-Founder, President and Chief Executive Officer George D. Yancopoulos — Co-Founder, President and Chief Scientific Officer Marion McCourt — Executive Vice…

How to protect against crime in the metaverse

By taking advantage of flaws in virtual systems and user behavior, such as malware infections, phishing scams and illegal access to personal and financial information, cybercriminals prey on the metaverse. Cybercriminals can target the metaverse in a variety of ways,…